











Manuscript version: Author’s Accepted Manuscript 
The version presented in WRAP is the author’s accepted manuscript and may differ from the 
published version or Version of Record. 
 
Persistent WRAP URL: 
http://wrap.warwick.ac.uk/144566                       
 
How to cite: 
Please refer to published version for the most recent bibliographic citation information.  
If a published version is known of, the repository item page linked to above, will contain 
details on accessing it. 
 
Copyright and reuse: 
The Warwick Research Archive Portal (WRAP) makes this work by researchers of the 
University of Warwick available open access under the following conditions.  
 
Copyright © and all moral rights to the version of the paper presented here belong to the 
individual author(s) and/or other copyright owners. To the extent reasonable and 
practicable the material made available in WRAP has been checked for eligibility before 
being made available. 
 
Copies of full items can be used for personal research or study, educational, or not-for-profit 
purposes without prior permission or charge. Provided that the authors, title and full 
bibliographic details are credited, a hyperlink and/or URL is given for the original metadata 
page and the content is not changed in any way. 
 
Publisher’s statement: 
Please refer to the repository item page, publisher’s statement section, for further 
information. 
 
For more information, please contact the WRAP Team at: wrap@warwick.ac.uk. 
 
Associations between socioeconomic deprivation and 
pharmaceutical prescribing in primary care in England 
 
Jessica Mooneya, Roger Yaua, Haseeb Moiza, Farah Kidya, Andrew Evansb, Sarah Hillmana,                       
Dan Todkilla, Saran Shantikumara 
 
 a Warwick Medical School, University of Warwick, Coventry, UK. 






Dr S Shantikumar, Clinical Lecturer in Public Health 
Room B163, Warwick Medical School, University of Warwick, Coventry, UK. CV4 7AL 









• Prescribing rates of many medications are associated with socioeconomic deprivation 
• We identify novel associations between prescribing and deprivation 
• Drugs prescribed at higher rates in more deprived practices include non-opioid analgesics 
and salbutamol 
• Contraceptives and travel vaccination prescriptions are associated with affluence 







Background Socioeconomic deprivation is associated with health inequality. Previous studies have 
described associations between primary care prescribing rates and deprivation for individual drugs or 
drug classes. We explore the correlation between socioeconomic deprivation and the rate of 
prescribing of individual pharmaceutical drugs, and drug classes, in primary care in England, to identify 
prescribing inequalities that would require further investigation.  
Methods In this cross-sectional study, national primary care prescribing data, by GP practice, were 
retrieved for the calendar year 2019 in England. Socioeconomic deprivation was quantified using the 
Index of Multiple Deprivation (IMD) score. Correlations were calculated using Spearman’s rank 
correlation coefficient (), adjusting for practice list size and demographics, with a Bonferroni-
corrected p value threshold of 5x10-5. 
Results We included 1.05 billion prescription items dispensed from 6896 England practices. 142/206 
(69%) drug classes and 505/774 (65%) drugs were significantly correlated with IMD score (p<5x10-5). 
Of the 774 included drugs, 31 (4%) were moderately positively associated with IMD score (>0.4). Only 
one was moderately negatively correlated with IMD score (< -0.4), suggesting higher prescribing 
rates in more affluent areas. The drug classes most strongly associated with IMD score included opioid 
and non-opioid analgesics, antipsychotics and reflux medications. Drug classes most strongly 
associated with affluence included adrenaline, combined oral contraceptives and hormone 
replacement therapy. 
Conclusion We identify novel associations of prescribing with deprivation. Further work is required 
to identify the underlying reasons for these associations so that appropriate interventions can be 
formulated to address drivers of inequality.   
 
Keywords:   common illnesses, community medicine, health disparities,  
primary care, socioeconomic status, underserved populations,  
Introduction 
Health inequalities may be reflected in prescribing rates across selected drug classes. For example, 
higher volumes of statins are prescribed in more socioeconomically deprived parts of England, even 
after adjusting for the increased prevalence of cardiovascular diseases and diabetes in these 
communities1. Although prescriptions for antibiotics are generally falling, there is 20% more antibiotic 
prescribing in the most deprived centile of England compared to the most affluent centile2. 
Benzodiazepines and opioids are also prescribed in higher rates in English primary care practices 
serving more deprived populations3,4. Whilst this may, in part, reflect a higher prevalence of chronic 
pain and anxiety disorders in these areas, other hypotheses are offered. For example, GPs in more 
socioeconomically deprived areas may be more likely to be under significant time pressures because 
of the higher level of healthcare demand in the communities they’re serving, in turn having less 
capacity for medication reviews. Furthermore, alternatives to medications, such as social prescribing, 
may not be as effective in areas where both resources and uptake are low5. Regardless of the 
underlying reasons, areas with increased prescribing are likely to have a higher incidence of 
medication-related side-effects and dependency. This iatrogenic morbidity could result in increased 
costs and even greater pressures on resources in these communities. It is also possible that some 
drugs are prescribed with higher frequency in areas of affluence.  
Understanding the relationship between deprivation and prescribing is the first step in exploring the 
underlying reasons for differential prescribing and identifying where prescribing may be optimised. 
The aim of this investigation was to explore the correlation between socioeconomic deprivation and 
the rate of prescribing of individual pharmaceutical drugs, and drug classes, in primary care in England, 




Data Sources  
This is a cross-sectional study using publicly available, nationally collected primary care data from 
England in 2019. Monthly primary care dispensing data between January and December 2019 were 
downloaded from NHS digital6, along with the age and sex distribution of registered patients at each 
GP practice7. These datasets include, for each GP practice in England, the number of items dispensed 
for each unique drug preparation, as defined by British National Formulary (BNF) codes. 
Socioeconomic deprivation was quantified using the national Index of Multiple Deprivation (IMD) 
score for 2019 - a relative measure of deprivation. IMD scores for each practice were obtained from 
Public Health England’s National General Practice Profiles8. 
Data Processing  
BNF codes are 15-character codes that specify a unique drug product, dose and formulation. A unique 
drug, irrespective of dose, formulation or route is identified from the first nine digits of the code, and 
a drug “class” was defined to be a BNF paragraph (e.g. antibacterials, fibrinolytic drugs), as identified 
by the first seven digits of the BNF code. Monthly prescribing data for 2019 were aggregated by 
practice to create a single dataset for the year. Separate aggregations were then made by (1) individual 
drug and (2) individual drug class. Prescribing data were linked, by a unique GP practice identifier, to 
practice list size, the proportion of over-65s and males in the practice, and practice IMD scores. Only 
drugs and drug classes from the first 14 chapters of the BNF were analysed. This excluded chapters on 
anaesthesia, preparations used in diagnosis (e.g. X-ray contrast media), “other drugs and 
preparations” (e.g. poison antidotes and homeopathic preparations), dressings and appliances (e.g. 
stoma bags). Rarely prescribed items, defined as fewer than 1000 prescriptions being dispensed over 





Prescribing rates were calculated as the number of items dispensed per 1000 registered patients in a 
practice. The association between drug, or drug class, prescribing rate and practice IMD score was 
calculated using Spearman’s rank correlation coefficient. Adjusted (partial) correlation coefficients 
were calculated to account for practice list size, the proportion of males and the proportion of over-
65s in each practice. All correlation coefficients presented here are adjusted. To account for multiple 
testing, a Bonferroni-adjusted significance threshold was used. We anticipated that there would be a 
maximum of 1000 tests performed, and thus set an a priori threshold of p < 5 x 10-5. Data were visually 
presented using bubble charts, with bubble size proportional to the total number of items prescribed. 
Adjusted correlation coefficient cut-offs of +/-0.2 and +/-0.4 represent weak and moderate 
correlations. All data processing and analysis was performed, and all plots generated, using the 
software R (v3.6)9. Interactive versions of the included figures, and the R code written to perform the 
analysis and generate the plots, are available on the GitHub page 
https://github.com/sirsazofduck/2020MooneyJ. No ethical approval was required as all datasets used 








In total, 774 drugs and 206 drug classes were included in the analysis, with 1.05 billion prescription 
items dispensed from 6896 practices. The prescribing rate of most analysed drugs have a significant 
association with practice IMD score, using the Bonferroni-adjusted p value threshold (Suppl. Figure 
S1). Medications are more likely to be positively correlated with IMD score than negatively correlated 
(see below and Figure 1), i.e. it is more common for drugs to be prescribed at higher rates in practices 
with more socioeconomically deprived patients, rather than at higher rates in more affluent practices.  
 
Individual Drugs and Drug Classes  
Of 206 included drug classes, 64 (31%) had an adjusted  between 0.2 and 0.4, and a further 30 (15%) 
had an adjusted  greater than 0.4. Only 4 drug classes (2%) had an adjusted correlation coefficient 
less than -0.2, with just one being moderately correlated with affluence (< -0.4, Suppl. Figure S2 and 
S3). Similar results were seen with individual drugs: of the 774 included drugs, 137 (18%) had an 
adjusted  between 0.2 and 0.4, and a further 31 (4%) had an adjusted  greater than 0.4, suggesting 
a moderate correlation between prescribing rate and IMD score. Conversely, only 10 drugs (1.2%) had 
an adjusted correlation coefficient less than -0.2, with only one drug having a correlation coefficient 
less than -0.4 (i.e. with prescribing rates that were higher in more affluent areas).  
The drug classes most strongly positively correlated with socioeconomic deprivation are shown in 
Table 1. These included both non-opioid and opioid analgesics (adjusted =0.67 and 0.57, 
respectively), adrenoreceptor agonists (=0.64, such as salbutamol) and drugs used to treat epilepsy 
(=0.56). Listing drugs individually, tramadol (=0.59) and gabapentin (=0.57) were most correlated 




Table 1. The ten drug classes with prescribing rates most positively correlated with Index of Multiple Deprivation score.  
The prescribing rates of these drug classes tend to be greater in more socioeconomically deprived practices. Ranking based on partial  values, adjusted for 
practice age and sex distribution and practice list size. Drug class defined as a paragraph within the British National Formulary. Number of items are aggregated 














              
  Unadjusted  Adjusted 
Drug Class Items Prescribed rho () p value   partial rho () p value 
Non-opioid analgesics  34,165,830 0.43 < 1 x 10-20  0.67 < 1 x 10-20 
Adrenoceptor agonists (e.g. salbutamol) 23,140,066 0.46 < 1 x 10-20  0.64 < 1 x 10-20 
Opioid analgesics 22,911,035 0.26 < 1 x 10-20  0.57 < 1 x 10-20 
Epilepsy medications 28,554,014 0.37 < 1 x 10-20  0.56 < 1 x 10-20 
Antimuscarinic bronchodilators 5,426,604 0.32 < 1 x 10-20  0.56 < 1 x 10-20 
Antispasmodic agents 4,614,661 0.30 < 1 x 10-20  0.54 < 1 x 10-20 
Topical non-steroidals and rubefacients 7,040,637 0.40 < 1 x 10-20  0.52 < 1 x 10-20 
Corticosteroids (respiratory) 21,016,562 0.27 < 1 x 10-20  0.52 < 1 x 10-20 
Nitrates 6,373,770 0.31 < 1 x 10-20  0.52 < 1 x 10-20 
Drugs used in nausea and vertigo 5,978,801 0.27 < 1 x 10-20   0.51 < 1 x 10-20 
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Drug classes that were most strongly negatively correlated with deprivation (i.e. that were prescribed 
at higher rates in more affluent areas) were those relating to allergic emergencies (= -0.49), 
combined hormonal contraceptives (= -0.33) and female sex hormones (hormone replacement 
therapy, = -0.24, Table 2). At the individual drug level, adrenaline prescribing was most strongly 
associated with affluence (= -0.48, Suppl. Table S2). Of the top ten drugs most correlated with 
affluence, six were female reproductive hormones used for contraception, menstrual bleeding 
disorders and hormone replacement therapy, and three were travel-related vaccines.  
A complete list of all studied drugs and drug classes, along with the unadjusted and adjusted 




Table 2. The ten drug classes with prescribing rates most negatively correlated with Index of Multiple Deprivation score.  
The prescribing rates of these drug classes tend to be greater in more affluent (less socioeconomically deprived) practices. Ranking based on partial rho 
values, adjusted for practice age and sex distribution and practice list size. Drug class defined as a paragraph within the British National Formulary. Number 
of items are aggregated across all included practices in 2019. 
              




rho ( p value   partial rho () p value 
Allergic emergencies (e.g. adrenaline auto-injectors) 377,707 -0.53 < 1 x 10-20  -0.49 < 1 x 10-20 
Preparations for vaginal/vulval changes 1,642,317 -0.56 < 1 x 10-20  -0.34 < 1 x 10-20 
Combined hormonal contraceptives/systems 3,658,554 -0.42 < 1 x 10-20  -0.33 < 1 x 10-20 
Female sex hormones & their modulators 3,913,946 -0.45 < 1 x 10-20  -0.24 < 1 x 10-20 
Herpesvirus infections 968,545 -0.37 < 1 x 10-20  -0.17 < 1 x 10-20 
Vehicles & emulsifying agents 69,865 0.00 0.9  -0.17 2.4 x 10-14 
Oral preparations for acne 104,077 -0.12 < 1 x 10-20  -0.15 < 1 x 10-20 
Sunscreening preparations 375,962 -0.38 < 1 x 10-20  -0.11 1.6 x 10-18 
Topical preparations for acne 1,546,097 -0.02 0.053  -0.09 1.7 x 10-13 




British National Formulary Chapters 
The BNF chapter with the drug classes having the greatest association with deprivation was that 
relating to the central nervous system (Figure 2). Other than opioid analgesics and drugs used to 
control epilepsy (which include gabapentin and pregabalin, both of which are also used in the 
management of chronic pain), this section includes antipsychotics (=0.49), selective serotonin 
reuptake inhibitors (such as fluoxetine, =0.42) and tricyclic antidepressants (=0.47). 
Another BNF chapter with a number of drug classes strongly correlated with deprivation was that 
relating to the respiratory system (Figure 3). All but one of these classes are prescribed in greater 
amounts in more deprived practices, including mucolytics (=0.47), theophylline (=0.42), and 
antihistamines (=0.38).  
In addition to the top ten list given in Table 1, other drug classes moderately positively correlated with 
deprivation include proton pump inhibitors (=0.44), insulin (=0.45), other antidiabetic drugs 
(=0.44), and antiplatelet agents (=0.40).   
A complete set of figures showing the correlation coefficients and significance of drug classes for each 






We explored the correlation between socioeconomic deprivation and the rate of prescribing of 
individual pharmaceutical drugs, and drug classes, in primary care in England, to identify prescribing 
inequalities that would require further investigation. Medication prescriptions for most individual 
drugs and drug classes increased with increasing deprivation. After adjusting for practice list size and 
age and sex make-up, this positive correlation was at least moderate for 31/774 (4%) of individual 
drugs and 30/206 (15%) of drug classes. Only one drug and one drug class were moderately negatively 
correlated with deprivation (prescribed more frequently in more affluent settings), although there 
were many other drugs with weaker statistically significant negative correlations. In seeking an 
explanation for these findings, further work would require an exploration of a combination of societal 
factors (including the wider determinants of health, such as education and employment), healthcare 
system factors (such as prescribing habits and staffing adequacy) and patient-level factors (such as 
differences in the prevalence of chronic disease).   
Comparison to Previous Literature 
Some of the associations found in this study align with previous research, and other findings are novel. 
The drug categories that are most strongly correlated with deprivation include analgesics, both opioids 
- such as tramadol and co-codamol - and non-opioids, including non-steroidal anti-inflammatory drugs 
(NSAIDs), gabapentin and pregabalin. An association between opioid prescribing and deprivation In 
England has previously been described3, although that study did not adjust for covariates. A recent 
review into medications associated with dependence by Public Health England also found that 
gabapentinoid and opioid use was associated with deprivation, and that co-prescribing of both drug 
classes was 1.4 times more common in the most deprived practices10. The prevalence of chronic pain 
has been shown to be correlated with low socioeconomic status, for both musculoskeletal11 and 
neuropathic pain12. Furthermore, deprivation is associated with poor outcomes following pain 
management13. Taken together, it is possible that the increased prescribing rate of analgesics in 
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deprived practices reflects the underlying prevalence and duration of chronic pain. However, further 
work is needed to exclude other potential contributors, such as lack of access to drug dependency 
services and the prevalence of complex mental health problems.   
There are many other health conditions whose prevalence varies with deprivation. This underlying 
variation may partially explain differential levels of prescribing. For example, epilepsy drugs (including 
those other than gabapentinoids) were found to have one of the strongest correlations with 
deprivation in this study. Epilepsy is known to have a higher incidence in more deprived areas14. 
Cardiovascular disease, asthma, COPD and diabetes have a well-characterised association with 
deprivation in terms of prevalence and severity15-20. Social and behavioural factors play a key role in 
the pathogenesis and severity of these conditions21. We found that drugs used to manage these 
chronic diseases are prescribed in higher rates in the most deprived areas, including nitrates, 
antiplatelets, lipid-lowering medications, inhalers, theophylline, and antidiabetic drugs such as 
metformin and insulin.  
A simple explanation for these findings would be that prescribing rates are purely a reflection of 
underlying disease burden and thus of healthcare need. However, there is a possibility that 
inequalities in prescribing or wider management exist in addition to inequalities in health status. 
Indeed, we previously found that higher rates of antipsychotics were prescribed in more deprived 
areas after adjusting for the prevalence of psychosis, dementia and depression, as well as for 
demographic factors22. In that case, the higher prescribing may reflect a lack of alternative non-
pharmacological management options in areas of socioeconomic deprivation, such as psychological 
therapy and social support, although this is yet to be investigated. In another study of asthma, we 
found that rates of salbutamol inhaler prescribing were higher in more deprived areas after adjusting 
for the prevalence of asthma, COPD and smoking23. High salbutamol use is related to inadequate day-
to-day management of asthma, and further investigation found that practices with higher salbutamol 
prescribing were also less likely to provide asthma patients with regular medication reviews. These 
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examples suggest that prescribing inequalities require investigation as they may highlight wider 
inequalities that need to be addressed beyond the mere prevalence or severity of a disease. 
Possibilities include issues with health literacy, inadequate provision for those using languages other 
than English, sub-cultural preferences for alternative therapies, and difficulties in attending 
appointments. 
Interestingly, prescribing in areas of women’s health is significantly correlated with deprivation, with 
both hormone replacement therapy (HRT) and combined oral contraception being prescribed more in 
affluent areas. A study from 2009 suggested that women from lower and middle social classes were 
less likely to use contraception in general24, and this may still be the case. We recently described the 
finding of increased HRT prescribing in areas of affluence, where this association remained after 
adjusting for additional factors that may influence prescribing, such as smoking, obesity and 
cardiovascular disease25. Whilst contraception can be obtained from alternative services, such as 
community genitourinary medicine clinics and pharmacies (which are not represented in the analysed 
data), our findings suggest the possibility of a gap of provision, or in accessing provision, of women’s 
healthcare services.  
Other novel associations found in this study include the higher rate of adrenaline and travel-related 
vaccine prescribing in more affluent practices, and the higher rate of antihistamine, antacid and 
topical dermatological agents, and of vitamin supplementation, in more deprived practices. In the case 
of adrenaline, which is often prescribed in the form of auto-injectors for those at risk of a severe 
allergic reaction, it is possible that individuals in more affluent areas are more likely to seek medical 
attention for allergies. The higher prescribing rates of certain upper gastrointestinal medications in 
areas of deprivation, along with vitamin supplements, may be influenced by differences in diet or in 
health-seeking behaviours, or may reflect an inability for individuals to afford over-the-counter 




Strengths, Limitations and Further Work 
This work examined prescribing in all NHS primary care practices in England, as captured by NHS 
Digital. As such, it has used a robust and unbiased data source for reviewing prescribing associations. 
The Index of Multiple Deprivation score was recently updated (in 2019), so the deprivation scores 
assigned to individual practices are an up-to-date marker of their population deprivation status. A 
hypothesis-free approach was taken to examining the associations between deprivation and 
prescribing, and a conservative p value threshold to account for multiple testing was used to minimise 
the risk of reporting falsely significant correlations. 
There are limitations to the current study. Firstly, data are from one year only, and prescription rates 
and deprivation were aggregated at the primary care practice level, so it is not known which 
individuals were given specific prescriptions, nor how many or for what reasons. For example, some 
epilepsy drugs may be prescribed for epilepsy or the management of pain, and it is impossible to 
identify the indications from aggregate data.  Secondly, the IMD score is used as a surrogate marker 
of deprivation but is not a direct measure. Finally, this study aimed to identify which drugs are 
potentially significantly associated with deprivation. It is important to acknowledge these as 
preliminary findings that need to be used as the foundation for further work, specifically examining 
prescribing at the individual patient level, adjusting for underlying clinical and demographic factors to 
confirm associations, and they may not apply to healthcare settings outside of England. Where these 
exist, investigation is required into the reasons for prescribing inequalities, to identify where 








Socioeconomic deprivation is correlated with higher rates of prescriptions for a large number drugs, 
though a few are also correlated with affluency. The reason behind many of these associations is 
unclear and may be explained through a combination of differences in disease prevalence rates, in the 
wider determinants of health including behavioural factors, in access to health and social care, and in 
the prescribing and management practices in different settings. More research is required into each 
of these associations to confirm the findings, to identify the underlying reasons for the observed 
inequality between communities, and to formulate appropriate interventions to ensure that every 
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Figure 1. Correlation coefficients of prescribing rates and practice Index of Multiple Deprivation 
score relationships by individual drug. 
Each bubble represents one drug, with the area of the bubble proportional to the number of items 
dispensed in 2019 in England. Drugs are ordered along the x-axis by their position in the British National 
Formulary (BNF) and colour-coded by chapter. Drug names and p values are not shown here but can 
be viewed on the interactive online version. A similar plot showing p values can be found in 
Supplementary Figure S1.  
 
Figure 2. Correlation coefficients of central nervous system drug classes and their association with 
Index of Multiple Deprivation score.  
Drug classes are given along the x-axis in their order in the British National Formulary (chapter 4). 
Bubble area is proportional to the number of prescriptions dispensed in primary care in 2019. 
Statistically significant associations are signified by red bubbles. A positive correlation coefficient 
reflects a tendency towards greater prescribing in more socioeconomically deprived practices. Some 
bubbles are annotated. All drug class names, number of items, correlation coefficients and p values 
can be viewed on the interactive online version. 
 
Figure 3. Correlation coefficients of respiratory system drug classes and their association with Index 
of Multiple Deprivation score.  
Drug classes are given along the x-axis in their order in the British National Formulary (chapter 3). 
Bubble area is proportional to the number of prescriptions dispensed in primary care in 2019. 
Statistically significant associations are signified by red bubbles. A positive correlation coefficient 
reflects a tendency towards greater prescribing in more socioeconomically deprived practices. Some 
bubbles are annotated. All drug class names, number of items, correlation coefficients and p values 
can be viewed on the interactive online version. 
 
